Evidence map›Paper›PMID 41595187›Full record

ArticleCancers2026

Wenkang Yu, Yizhu Mao, Yifei Yin, Jiacheng Yang, Yi Zhang, Xuandong Huang, Yifen Zhang, Chenxia Jiang, Rongxi Yang

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenkang YuDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Yizhu MaoDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Yifei YinDepartment of Thyroid and Breast Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an 223002, China.
Jiacheng YangDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Yi ZhangDepartment of Pathology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Xuandong HuangDepartment of Thyroid and Breast Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an 223002, China.
Yifen ZhangDepartment of Pathology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.ORCID 0009-0001-4334-5493
Chenxia JiangDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong 226001, China.
Rongxi YangDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.

Funding

Nanjing Medical University 2018RC0003the Natural Science Foundation of Huai'an HAB2024021the Wu Jieping Medical Foundation Special Fund for Tumor Targeted Research 320.6750.2022-19-71
6 · The paper itself

Abstract

background

methods

results

conclusions

Indexed as

BCAR3biomarkerDNA methylationEMTthyroid cancer

Identifiers

PMID41595187
PMCPMC12839260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.